| Identification | Back Directory | [Name]
GLPG2938 | [CAS]
2130996-00-6 | [Synonyms]
GLPG2938
1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea
GLPG2938,GLPG 2938,Lysophospholipid Receptor,fibrosis,inhibit,LPL Receptor,GLPG-2938,selective,pulmonary,Inhibitor,potent,idiopathic | [Molecular Formula]
C20H19F6N7O2 | [MDL Number]
MFCD34563730 | [MOL File]
2130996-00-6.mol | [Molecular Weight]
503.4 |
| Chemical Properties | Back Directory | [Boiling point ]
585.9±50.0 °C(Predicted) | [density ]
1.49±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF:10.0(Max Conc. mg/mL);19.86(Max Conc. mM)
DMSO:51.5(Max Conc. mg/mL);102.3(Max Conc. mM)
Ethanol:1.0(Max Conc. mg/mL);1.99(Max Conc. mM) | [form ]
A solid | [pka]
11.73±0.46(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Biological Activity]
GLPG2938 is an orally activepotent and selective S1P2 receptor (S1PR2) antagonist (GTPγS induction IC50 = 29 nM; [S1P] = EC80) with no activity against other S1P receptors. GLPG2938 inhibits sphingosine 1-phosphate (S1P)-induced cellular responses in cultures (Ca2+ flux IC50 = 8.8 nM & IL8 release IC50 = 3.8 nM; [S1P] = EC80) and exhibits good efficacy in a 14-day model of bleomycin-induced pulmonary fibrosis in mice in vivo (13and 10 mg/kg b.i.d. p.o.) with good pharmacokinetics. |
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Website: |
http://www.yuhua99.com/ShowSupplierProductsList927327/0.htm |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
| Company Name: |
|
| Tel: |
|
| Website: |
www.sangon.com |
|